Status:
UNKNOWN
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Liver Cirrhosis
Esophageal Varices Bleeding
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A prospective, randomized controlled study on whether re-education after discharge can reduce the rebleeding rate after endoscopic treatment of esophageal and gastric varices in patients with liver ci...
Detailed Description
After receiving esophageal variceal ligation and （or） gastric fundus variceal sclerotherapy, patients with outside hospitalthe rate of bleeding due to liver cirrhosis shall be re-educated outside the ...
Eligibility Criteria
Inclusion
- Esophageal and / or gastric varices ；
- liver cirrhosis ；
- patients receiving endoscopic treatment (esophagogastric variceal sclerosis and/or ligation) ；
- All subjects or their guardians must sign the subject consent form before entering the test
Exclusion
- Patients with mental illness, severe hearing loss and unable to take care of themselves ;
- ASA score ≥ grade IV at discharge ;
- Hepatic encephalopathy ≥ stage II;
- Patients with liver cancer;
- Pregnant and lactating women;
- Patients who cannot sign informed consent
Key Trial Info
Start Date :
February 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 19 2024
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT05302661
Start Date
February 19 2022
End Date
February 19 2024
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital
Jinan, Shandong, China, 250012